Skip to main content

Table 5 Association between free testosterone and odds of offspring developing autism

From: Sex-specific and sex-independent steroid-related biomarkers in early second trimester maternal serum associated with autism

Cohort

Mean

Range

SD

Crude modelsa

Adjusted modelsa,b

OR

95% CI

P Value

AOR

95% CI

P Value

Overall (N = 134)

1.27

0.00–4.91

0.88

1.01

0.68–1.48

0.98

1.08

0.68–1.71

0.74

By sex

Males (n = 80)

1.31

0.00–4.91

0.95

0.84

0.53–1.36

0.483

1.05

0.62–1.79

0.846

Females (n = 54)

1.20

0.04–3.26

0.76

1.35

0.64–2.84

0.434

0.53

0.18–1.62

0.265

By gestational age categoryc

Term (n = 96)

1.26

0.06–4.02

0.78

0.96

0.57–1.63

0.888

0.96

0.51–1.83

0.906

Preterm (n = 38)

1.27

0.00–4.91

1.1

1.08

0.58–2.03

0.809

1.01

0.49–2.08

0.981

  1. aOR and AOR are calculated for every 1 pg/ml increase in free testosterone
  2. bAdjusted for Principal Component Factor 1 (gestational age, birthweight), Principal Component Factor 2 (maternal age, paternal age, maternal education duration, paternal education duration), pre-pregnancy body mass index (BMI), gestational weight gain, newborn sex. When stratified by sex, sex was removed as a covariate. When stratified by gestational age category, principal component factor 1 was replaced with birthweight
  3. cPreterm < 37 weeks gestation; term ≥ 37 weeks gestation